Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
Oita Venture Capital
OitaPre-Seed–Growth
1 person
Amathaon Capital
MunichSeed–Growth$770K – $1.3M
10 people
DBH Investment Zrt.
BudapestSeed–Series B$216K – $1.6M
10 people
Easton Capital
New YorkSeed–Late Stage$10M – $20M
7 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
9 people
DeepTech & Climate Fonds
MunichSeed–Late Stage$5.5M – $55M
3 people
Eurazeo
ParisSeries A–Late Stage
12 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Kama Flow
MoscowSeed–Late Stage
2 people
Cycad Group LLC
Santa BarbaraSeed–Late Stage
4 people
DeepWork Capital
OrlandoSeed–Series B
10 people
Averin Capital
New YorkSeed–Growth
9 people
Cure Kids Ventures
AucklandSeed–Growth
6 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage
Kinnevik
StockholmSeed–Late Stage
Pivotal bioVenture Partners
San FranciscoSeed–Late Stage
12 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
8 people
Angelini Ventures
RomeSeed–Growth
4 people
GLOCAL Latam
RosarioPre-Seed–Growth$500K
7 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
Ming capital
ShenzhenSeed–Late Stage
6 people
Ontario Centre of Innovation programs
TorontoPre-Seed–Growth
3 people
Black Diamond Ventures
GlendalePre-Seed–Late Stage$2M – $10M
8 people
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.

























































